zoledronic acid has been researched along with HIV in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pauza, CD; Poonia, B | 1 |
1 other study(ies) available for zoledronic acid and HIV
Article | Year |
---|---|
Gamma delta T cells from HIV+ donors can be expanded in vitro by zoledronate/interleukin-2 to become cytotoxic effectors for antibody-dependent cellular cytotoxicity.
Topics: Anti-Retroviral Agents; Antibody-Dependent Cell Cytotoxicity; CD56 Antigen; Cell Line, Tumor; Diphosphonates; GPI-Linked Proteins; Hemiterpenes; HIV; HIV Infections; Humans; Imidazoles; Immunophenotyping; Interleukin-2; Lymphocyte Activation; Organophosphorus Compounds; Receptors, Antigen, T-Cell, gamma-delta; Receptors, IgG; T-Lymphocytes; Zoledronic Acid | 2012 |